SourceDigital Trends•Stalecollected in 2m
NHS pilots PARO robot seals for mental health care
Explore how embodied AI and affective robotics are being deployed in real-world clinical environments.
30-Second TL;DR
What Changed
PARO is a therapeutic robot designed to look like a baby seal
Why It Matters
This highlights the growing role of embodied AI and robotics in specialized healthcare settings. It demonstrates how non-human agents can effectively manage patient emotional states.
What To Do Next
Research the integration of tactile sensors and affective computing in robotics to improve human-robot interaction design.
Who should care:Developers & AI Engineers
Key Points
- •PARO is a therapeutic robot designed to look like a baby seal
- •Pilot program launched by NHS trust in Kent and Medway
- •Targeting patients with learning disabilities to improve comfort
- •Focus on non-pharmacological interventions for anxiety
Key numbers$6,000$6,400
Deep Insight
Background and context from public sources — not the original article. 31 sources cited.
Enhanced Key Takeaways
- •PARO was developed by Dr. Takanori Shibata of Japan's National Institute of Advanced Industrial Science and Technology (AIST), with development commencing in 1993 and the robot first exhibited publicly in late 2001.
- •It was classified as a Class 2 medical device by U.S. regulators in the fall of 2009, recognizing its therapeutic applications.
- •Beyond learning disabilities, PARO has been extensively used in care facilities globally for dementia patients, and studies have also explored its benefits for individuals with autism spectrum disorder and PTSD.
- •Research indicates that PARO can reduce patient and caregiver stress, stimulate social interaction, improve relaxation, motivation, and sociability, and has shown a moderate effect on reducing medication use for behavioral and psychological symptoms of dementia.
- •The robot is handmade, contributing to its cost, which was approximately $6,000-$6,400 in the US around 2017-2020, and around ¥420,000-¥500,000 in Japan as of 2026.
Competitor Analysis
Primary Focus
- PARO (Therapeutic Robot)
- Emotional support, stress reduction, non-pharmacological therapy
- ElliQ (Companion Robot)
- Proactive companionship, health reminders, cognitive activities
- Lovot (Robotic Companion)
- Emotional comfort, non-verbal interaction
- Buddy (Companion Robot)
- Emotional support, social connection, safety, cognitive stimulation
Appearance
- PARO (Therapeutic Robot)
- Baby harp seal (non-humanoid)
- ElliQ (Companion Robot)
- Desktop device with moving head (non-humanoid)
- Lovot (Robotic Companion)
- Animal-like (non-humanoid)
- Buddy (Companion Robot)
- Humanoid-like (mobile robot)
Interaction Style
- PARO (Therapeutic Robot)
- Tactile, sound, light, posture-responsive, learns user preferences
- ElliQ (Companion Robot)
- Conversational, proactive, personalized, remembers past talks
- Lovot (Robotic Companion)
- Non-verbal, responds to affection
- Buddy (Companion Robot)
- Conversational (generative AI), telepresence, emotional behaviors
Target User
- PARO (Therapeutic Robot)
- Patients with dementia, learning disabilities, autism, PTSD, elderly
- ElliQ (Companion Robot)
- Seniors, older adults
- Lovot (Robotic Companion)
- General companionship, emotional support
- Buddy (Companion Robot)
- Seniors, older adults
Medical Device Classification
- PARO (Therapeutic Robot)
- FDA Class 2 Medical Device (US)
- ElliQ (Companion Robot)
- Not specified as medical device
- Lovot (Robotic Companion)
- Not specified as medical device
- Buddy (Companion Robot)
- Not specified as medical device
Pricing (Approx.)
- PARO (Therapeutic Robot)
- $6,000 - $6,400 (US, 2017-2020); ¥420,000 - ¥500,000 (Japan, 2026)
- ElliQ (Companion Robot)
- Subscription-based model (details vary)
- Lovot (Robotic Companion)
- Not readily available, generally high-end consumer
- Buddy (Companion Robot)
- Quote-based (enterprise/care facilities)
Key Technologies
- PARO (Therapeutic Robot)
- Dual 32-bit processors, multiple sensors (tactile, light, audition, temperature, posture), AI learning functions, antibacterial fur
- ElliQ (Companion Robot)
- Advanced AI, natural language processing, emotional AI
- Lovot (Robotic Companion)
- AI for emotional expression, tactile sensors
- Buddy (Companion Robot)
- Advanced emotional AI, generative AI (ChatGPT integration), telepresence
Battery Life
- PARO (Therapeutic Robot)
- ~5 hours of use per charge
- ElliQ (Companion Robot)
- Not specified
- Lovot (Robotic Companion)
- Not specified
- Buddy (Companion Robot)
- Not specified
| Feature/Category | PARO (Therapeutic Robot) | ElliQ (Companion Robot) | Lovot (Robotic Companion) | Buddy (Companion Robot) |
|---|---|---|---|---|
| Primary Focus | Emotional support, stress reduction, non-pharmacological therapy | Proactive companionship, health reminders, cognitive activities | Emotional comfort, non-verbal interaction | Emotional support, social connection, safety, cognitive stimulation |
| Appearance | Baby harp seal (non-humanoid) | Desktop device with moving head (non-humanoid) | Animal-like (non-humanoid) | Humanoid-like (mobile robot) |
| Interaction Style | Tactile, sound, light, posture-responsive, learns user preferences | Conversational, proactive, personalized, remembers past talks | Non-verbal, responds to affection | Conversational (generative AI), telepresence, emotional behaviors |
| Target User | Patients with dementia, learning disabilities, autism, PTSD, elderly | Seniors, older adults | General companionship, emotional support | Seniors, older adults |
| Medical Device Classification | FDA Class 2 Medical Device (US) | Not specified as medical device | Not specified as medical device | Not specified as medical device |
| Pricing (Approx.) | $6,000 - $6,400 (US, 2017-2020); ¥420,000 - ¥500,000 (Japan, 2026) | Subscription-based model (details vary) | Not readily available, generally high-end consumer | Quote-based (enterprise/care facilities) |
| Key Technologies | Dual 32-bit processors, multiple sensors (tactile, light, audition, temperature, posture), AI learning functions, antibacterial fur | Advanced AI, natural language processing, emotional AI | AI for emotional expression, tactile sensors | Advanced emotional AI, generative AI (ChatGPT integration), telepresence |
| Battery Life | ~5 hours of use per charge | Not specified | Not specified | Not specified |
Technical Deep Dive
- Processors: Outfitted with dual 32-bit processors.
- Sensors: Incorporates five types of sensors: tactile (including 12 covering its fur and touch-sensitive whiskers), light, audition (three microphones for sound recognition and localization), temperature, and posture sensors.
- Actuators: A delicate system of motors and actuators silently moves its limbs and body, enabling movements like tail wagging, eye opening/closing, and head/flipper movements.
- Artificial Intelligence (AI): Features built-in AI that simulates believable physical behaviors, learns user's preferred actions, remembers faces, adapts to communication styles, and can distinguish up to 50 voices.
- Sound: Produces sounds that imitate a real baby harp seal, based on recordings made in Canada.
- Fur: Covered in artificial antibacterial fur, which contains silver-ion (Ag+) to gradually kill bacteria and viruses.
- Power: Operates on a rechargeable battery, providing approximately 5 hours of continuous use per charge, with a full charge taking about 3 hours. The battery pack is recommended to be replaced every two years. It can also operate continuously when plugged into an AC adaptor.
- Weight: Weighs approximately 2.5 kg.
- Medical Device Status: Certified as an FDA Class II Medical Device in the U.S., classified as biofeedback equipment.
Future ImplicationsAI analysis grounded in cited sources
Therapeutic robots like PARO will see increased integration into public health systems for non-pharmacological interventions.
PARO's classification as a Class 2 medical device and its adoption by various countries' public medical and welfare systems, alongside ongoing pilot programs such as the NHS one, indicate a growing trend towards wider acceptance and potential reimbursement for robot-assisted therapy.
The application of therapeutic robots will expand to a broader range of mental health conditions and age groups.
While initially focused on dementia, PARO has demonstrated benefits for children with autism, PTSD, and general anxiety, suggesting its versatility and potential for wider adoption across diverse patient populations beyond its current primary use.
Future therapeutic robots will incorporate more sophisticated conversational and personalized AI features.
Competitors like ElliQ and Buddy are already integrating advanced AI, including generative AI, and focusing on personalized conversations and proactive engagement, which will likely drive the evolution of therapeutic robots beyond non-verbal interaction.
Timeline
1993
Dr. Takanori Shibata begins development of animal-type therapeutic robots.
2001
PARO is first exhibited to the public.
2003
PARO begins use in Japan and Europe and is a 'Best of COMDEX' finalist.
2005
PARO is commercialized in Japan as its 8th generation.
2009 Fall
U.S. regulators classify PARO as a Class 2 medical device.
2022-09
A study published in Clinical Gerontologist shows PARO intervention alleviated depression and loneliness for older adults with dementia.
- 1993Dr. Takanori Shibata begins development of animal-type therapeutic robots.
- 2001PARO is first exhibited to the public.
- 2003PARO begins use in Japan and Europe and is a 'Best of COMDEX' finalist.
- 2005PARO is commercialized in Japan as its 8th generation.
- 2009 FallU.S. regulators classify PARO as a Class 2 medical device.
- 2022-09A study published in Clinical Gerontologist shows PARO intervention alleviated depression and loneliness for older adults with dementia.
Sources (31)
Factual claims are grounded in the sources below. Forward-looking analysis is AI-generated interpretation.
1Google Search Sourcevertexaisearch.cloud.google.com2Google Search Sourcevertexaisearch.cloud.google.com3Google Search Sourcevertexaisearch.cloud.google.com4Google Search Sourcevertexaisearch.cloud.google.com5Google Search Sourcevertexaisearch.cloud.google.com6Google Search Sourcevertexaisearch.cloud.google.com7Google Search Sourcevertexaisearch.cloud.google.com8Google Search Sourcevertexaisearch.cloud.google.com9Google Search Sourcevertexaisearch.cloud.google.com10Google Search Sourcevertexaisearch.cloud.google.com11Google Search Sourcevertexaisearch.cloud.google.com12Google Search Sourcevertexaisearch.cloud.google.com13Google Search Sourcevertexaisearch.cloud.google.com14Google Search Sourcevertexaisearch.cloud.google.com15Google Search Sourcevertexaisearch.cloud.google.com16Google Search Sourcevertexaisearch.cloud.google.com17Google Search Sourcevertexaisearch.cloud.google.com18Google Search Sourcevertexaisearch.cloud.google.com19Google Search Sourcevertexaisearch.cloud.google.com20Google Search Sourcevertexaisearch.cloud.google.com21Google Search Sourcevertexaisearch.cloud.google.com22Google Search Sourcevertexaisearch.cloud.google.com23Google Search Sourcevertexaisearch.cloud.google.com24Google Search Sourcevertexaisearch.cloud.google.com25Google Search Sourcevertexaisearch.cloud.google.com26Google Search Sourcevertexaisearch.cloud.google.com27Google Search Sourcevertexaisearch.cloud.google.com28Google Search Sourcevertexaisearch.cloud.google.com29Google Search Sourcevertexaisearch.cloud.google.com30Google Search Sourcevertexaisearch.cloud.google.com31Google Search Sourcevertexaisearch.cloud.google.com
Weekly AI Recap
Read this week's curated digest of top AI events →
Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: Digital Trends ↗
This is a summary, not the original. Read the source, or get the weekly briefing.
The weekly digest
One email a week. Unsubscribe anytime.